The results have been thus far inconsistent among tumor types and somewhat confusing, with reports supporting both an improved and a decreased OS conferred by high expression, a phenomenon that resonates the previously mentioned shortcomings of the assessment of PD-L1. The gene discussed is CD274; the disease is neoplasm.